Abstract:Background and aimsTriple-negative breast cancer (TNBC) is a subtype of breast cancer with a poor prognosis due to its aggressive biological behavior and lack of therapeutic targets. Here, we aimed to identify specific biomarkers for TNBC by using RNA-sequencing and bioinformatics analysis.Materials and methodsFresh breast tumor tissues were obtained from 34 patients who were admitted to the Breast Center, Peking University People’s Hospital, from June 2020 to December 2020; the patients were pathologically diagnosed with primary breast cancer and underwent surgery for the resection of tumor tissues. Tumor-tissue RNA was extracted and the generated cDNA libraries were sequenced using the NextSeq platform, after which the differentially expressed genes (DEGs) between TNBC and other subtypes of breast cancer were identified and DEG functional-enrichment analysis was performed. Next, weighted gene co-expression network analysis (WGCNA) was used to identify the most significant module and hub genes in TNBC, and then the correlations between the hub genes and the prognosis of TNBC patients were analyzed through survival analysis. Lastly, qRT-PCR analysis was used to validate the expression levels of hub genes in tumor tissues from TNBC and other subtypes of breast cancer.ResultsComparison of TNBC tissues and tissues from other subtypes of breast cancer led to the identification of 273 DEGs in TNBC: 172 upregulated and 101 downregulated genes. In Gene Ontology analysis of the DEGs, five terms were significantly enriched, “developmental process,” “anatomical structure development,” “tissue development,” “cell cycle,” and “epithelium development,” and in Kyoto Encyclopedia of Genes and Genomes pathway analysis, the most significantly enriched pathways for all DEGs were “cell cycle,” “mitophagy-animal,” and “autophagy-animal.” Furthermore, we identified the core module related to TNBC and screened for hub genes by using WGCNA, and after verifying the top 100 genes based on survival analysis, we selected four genes as the hub genes: SERPINB4, SMR3A, FERMT1, and STARD4; elevated expression of these genes was associated with poor overall survival (OS) of TNBC patients. Notably, qRT-PCR results indicated that FERMT1 mRNA expression was significantly upregulated in TNBC samples.ConclusionThe DEG profiles between tissues from TNBC and other subtypes of breast cancer were identified using RNA-sequencing and bioinformatics analysis. FERMT1 was significantly upregulated in TNBC tumor tissues, and increased expression of FERMT1 was associated with poor OS of TNBC patients. FERMT1 could serve as a specific biomarker of and therapeutic target in TNBC.

Molecular biology: new tools for studying microbial ecology.

Telomere-Associated Gene Signatures Correlate with Prognosis, Tumor Microenvironment, and Chemosensitivity in Breast Cancer.

Identification and characterization of critical genes associated with tamoxifen resistance in breast cancer

Identification of Novel Prognostic Genes of Triple-Negative Breast Cancer Using Meta-Analysis and Weighted Gene Co-Expressed Network Analysis.

Network-based approach to identify prognostic biomarkers for estrogen receptor–positive breast cancer treatment with tamoxifen

Transcriptome profiling identified differentially expressed genes and pathways associated with tamoxifen resistance in human breast cancer

On User Interaction Behavior as Evidence for Computer Forensic Analysis

Identifying Biomarkers to Predict the Progression and Prognosis of Breast Cancer by Weighted Gene Co-expression Network Analysis

Estrogen receptor—positive breast cancer survival prediction and analysis of resistance–related genes introduction

Identification of Hub Genes and Upstream Regulatory Factors Based on Cell Adhesion in Triple-negative Breast Cancer by Integrated Bioinformatical Analysis

Exploring the Molecular Mechanism of the Drug-Treated Breast Cancer Based on Gene Expression Microarray

Screening of potential hub genes and key pathways associated with breast cancer by bioinformatics tools

Characterization of an enterovirus associated with acute infectious lymphocytosis.

Comprehensive Molecular Analyses of an M2-Like Tumor-Associated Macrophage for Predicting the Prognosis and Immunotherapy in Breast Cancer

Novel Biomarkers Identified in Triple-Negative Breast Cancer Through RNA-sequencing

Identification of hub genes in bladder transitional cell carcinoma through ceRNA network construction integrated with gene network analysis

Identification of a five genes prognosis signature for triple-negative breast cancer using multi-omics methods and bioinformatics analysis

Development and Validation of a Novel Stemness-Index-Related Long Noncoding RNA Signature for Breast Cancer Based on Weighted Gene Co-Expression Network Analysis

PROCESS OPTIMIZATION OF CRUDE PALM OIL BIODIESEL PRODUCTION BY RESPONSE SURFACE METHODOLOGY

Identification Of A Cerna Network In Lung Adenocarcinoma Based On Integration Analysis Of Tumor-Associated Macrophage Signature Genes

Identification of Potential Crucial Genes and Key Pathways in Breast Cancer Using Bioinformatic Analysis